Tobacco and Vapes Bill (Eleventh sitting)

Clause 99 relates to testing. The clause allows the Secretary of State powers so they may by regulation require a person specified in the regulations, such as manufacturers, importers or other relevant parties, to carry out tests on the products to ensure they comply with any of the registered requirements. Testing is a sensible thing to be able to do, subject to making provision for far more new tests to be carried out, because it is important that testing is done properly. Some examples of where the Secretary of State has given flexibility include the timing and methodology; where, when and how the tests are to be done; who is authorised to carry out testing on behalf of the specified person, so whether a manufacturer or a third party can undertake testing themselves; how the products are to be tested, for example if all products are to be tested or just a sample; whether samples are required to be provided to a third party for testing; and whether there will be any charges for tests, which could be set based on the costs involved or other regulations. Subsection (3) states that charges will apply and subsection (2)(e) allows regulations to specify how those charges will be used, including provision on whether the fees collected can be kept by the authority responsible for testing or whether they should be paid into a consolidated fund via the Government’s general revenue. Subsection (4) states that any regulations under this section are subject to the affirmative resolution procedure, so voted for in Committee. I have a few points to raise. The clause gives the Secretary of State the power to specify a person who would be required to carry out the test. It is important to clarify who that person might be, and whether it refers to manufacturers, importers, independent testing bodies or other stakeholders. As I have already mentioned, it would not be reasonable to get big tobacco companies to mark their own homework, so how will the Secretary of State determine who is specified for those tasks? Additionally, once the product is tested and deemed compliant, will there be any follow up or long-term monitoring of product safety and health impact over time? There is post-market surveillance for medical devices, but what mechanisms will be in place to monitor the ongoing compliance with consumer products post market? At the moment, it seems that all a company needs to do is say what is in a product, be believed and be registered with the Medicines and Healthcare products Regulatory Agency. Currently, that happens simply on a company’s word. I am sure that in most cases—perhaps almost all—the company’s information is fair and true, but, in some cases, as has already been shown, that has not been the case, so it is important to consider that issue. Furthermore, the phrase “selection of products for testing” in subsection (2)(c) is vague and could be exploited. The provision could allow a situation where only certain products are selected for testing, potentially skewing the results if products likely to fail are excluded from the testing process. If it is not properly regulated, that could result in cherry-picking, where only the “cleanest products” are tested to ensure they meet regulatory requirements. There will clearly be some cost to industry for testing. Does the Minister have any further information on how much those costs will be? Based on the impact assessment, costs for the testing requirements and the testing of individual components could be quite high, so will the Minister provide more information about that?

It is a pleasure to serve under your chairmanship once again, Sir Roger. I am sure the shadow Minister can come in after me if she wishes to opine on clause 100. Clause 99 grants the Secretary of State the authority to introduce and amend regulations concerning tobacco and vaping products. The provision ensures flexibility and responsiveness in the ever-evolving landscape of tobacco control that we have talked about previously. It is vital to ensure that the UK’s tobacco and vape regulations remain robust and up to date, especially given the increasing prevalence of vaping among young people and the emergence of new tobacco alternatives. There are a number of real positives about clause 99. First, it provides adaptability to emerging public health concerns. The regulatory flexibility allows the Secretary of State and his Ministers to swiftly address any new health risks. A 2021 study by Action on Smoking and Health UK found that youth vaping rates had risen from 4% in 2020 to 7% in 2021, so, by ensuring that new products can be regulated promptly, clause 99 provides a mechanism for responding to those emerging trends. The clause aligns us with international partners and best practices, and with global tobacco control standards, such as the World Health Organisation’s framework convention on tobacco control. Nations such as Canada and Australia have successfully implemented similar regulatory powers to adapt quickly to the new threats posed by novel tobacco products, demonstrating that adaptable regulations lead to better public health outcomes. The final positive of the clause is the stronger consumer protections. Without the ability to introduce rapid regulatory amendments, harmful substances may enter the UK market. As I have mentioned, in 2019 illicit vaping products containing vitamin E acetate led to serious lung illnesses, noted in the US. By strengthening the regulatory framework, Government can proactively prevent such issues. I have a couple of potential challenges. First, as I mentioned, there is always potential for malign industry influence. The tobacco and vaping industries have a history of lobbying against stringent regulations. Indeed, since this Bill Committee has been sitting over the past week or so, my inbox has filled with such representations. The UK must ensure transparency and public health prioritisation in all its regulatory decisions. Secondly, in balancing the public health and economic impacts, we have to be careful about over-regulation possibly stifling innovation within the vaping industry, which some argue plays a role in harm reduction by helping smokers quit traditional cigarettes. Opposition Members have made that point a number of times: we want to ensure that the regulations are effective and robust, but, where vaping is being used as a smoking cessation tool, the regulations must be flexible enough to allow novel products to come on to the market, which could in future help smokers even further. Clause 100 clarifies the scope and the applicability of the Bill, which means that it ensures coherence of enforcement. A clear definition of which products and businesses fall under the new rules will prevent, I think, ambiguity in their implementation. The positives of this clause are that, where there is clear application, the reduced ambiguity in interpretation and enforcement means that businesses will understand their obligations and consumers will know their rights. That is absolutely essential. For example, the smoke-free public places legislation that came into effect in 2007 clearly benefited from the defined scope, which reduced any legal disputes. By defining the reach of the Bill, clause 100 allows authorities to target enforcement promptly. Without clear application provisions, which we see in this clause, regulatory loopholes could be exploited. The clause closes them. Likewise, tobacco companies may attempt to bypass our regulations by selling non-compliant products online from overseas suppliers. Again, the strong application in clause 100 ensures that the law extends to online and cross-border sales. However, perhaps the Minister will outline how he understands that that will be enforced. That brings me to my real concern, or I suppose question, about clause 100. The risk of online sales makes enforcement much more complex than it would have done had we introduced such a Bill 10, 15 or 20 years ago. How will the UK work with other international bodies to curb illicit cross-border sales, especially when things are sold online? Also—I have mentioned this point before, but I will continue to do so—when small retailers are struggling with compliance, there has to be some form of education and support for them from Government so that they can comply. The majority of the vaping industry, where we have decided it is legal, obviously needs a clear set of guidelines from the Department and the regulatory bodies to comply with the regulations.

Clause 100 concerns product safety, which is important. Even when a product is not safe, it should still be as safe as it can be and should contain only those things that are expected. When Lincolnshire police took a sample of vape devices from children from a school in my constituency, they found that many of the vapes contained dangerous ingredients that should not have been in there, including, in one case, I believe, an ingredient banned in the UK for many decades. Clause 100 is important: the Minister must ensure that items on the market are safe. I come back to the evidence from Dr Laura Squire from the MHRA. She said that licensing a medical product does not mean that it is safe, and that these vapes are not medical products either. I am grateful to the Minister for saying in the last session that he is looking for a new home for the licensing and registration process for vapes and vaping products, because “MHRA-registered” suggests to the consumer that those things are in some way safer and more fully tested than they have been. Clause 100 suggests very sensible regulation, but it gives the Minister the power to do that without significant oversight, even though the affirmative procedure applies. Since clause 90, all the Bill has done is to confer powers on the Secretary of State to regulate without actually providing a huge amount of detail on the Secretary of State’s intent. One never knows what the intent of a future Secretary of State could be in this regard. Will the Minister comment on why regulation will be in secondary legislation rather than being detailed in the Bill? I understand the need to be agile and to think quickly to try to stay ahead of an industry that will try to adapt to addict more people to nicotine in other forms, but it would have been possible for the Minister to put much of that detail in the Bill, and to have taken a power in a final clause to amend parts of those regulations by statutory instrument. Most of the intent and most of the regulation would then have been known very quickly, but could be altered and adapted later. Why has the Minister taken the approach that he has, rather than a more up-front approach? Clause 100(1)(a) requires “producers or importers to have processes in place”. Again, this is an important point. Most of these products seem to be made overseas, where of course the UK courts do not have jurisdiction. It is at the point of import, and with regards to the person who is importing, that we may need to be more responsible than with a producer where the items are made overseas. I also urge the Minister, echoing the point made by my hon. Friend the Member for Farnham and Bordon, to consider online sales. We see already that some regulations that are in place for the real world rather than the virtual world create loopholes for regulations to be circumvented. Clearly, public safety has to be the Government’s first priority. The testing in clause 99 and the product safety regulations in clause 100 are a welcome initiative, but clearly the devil will be in the detail and the detail is not available to us today.

I am sorry that your croakiness is getting the better of you, Sir Roger, but hopefully you will be on fine form tomorrow for the private Member’s Bills—I am not sure whether the Whips on either side of the House are praying for that. On clauses 99 and 100, I will go through the questions posed by the shadow Minister and the hon. Member for Farnham and Bordon. It is the responsibility of trading standards to test products if they believe a product contains illegal substances or could contain too much nicotine. Trading standards currently test products on an ad-hoc basis, which is contingent on funding. We aim to establish a testing regime to regularly check that products on the shelves are what they say they are. That will support overall enforcement, will ensure that registered products are safe for consumers and will allow retailers, in both brick-and-mortar establishments and online, to have greater clarity about and confidence in the products that they are able to stock to sale. It is really important to consider online sales as a growing area. These measures have to be taken within the wider context of clauses and measures that we have already debated, in that any product for sale in the United Kingdom, whether in a shop or online, will have to be registered, and any retailer, whether a shop or online, will have to have the appropriate licences in place. There are clear and substantial penalties for breaching those licensing arrangements, and there are real and substantial consequences for selling products that are not in accordance with the descriptions on the registration of those products. When all of that is put into context, and testing is added in, we believe that this will be a robust regime.

Speaker

11:45:00

Speaker

We are taking these new powers because, unlike with cigarettes, there is no current testing regime for vapes, nicotine products, heated tobacco products, or herbal products. Testing nicotine vapes is currently carried out on a pretty ad hoc basis—subject to resource—local authority to local authority. That is not the consistent approach that we want to see. We have already seen—indeed the shadow Minister has referred to this happening in Lincolnshire—that some notified products contain heavy metals and dangerous substances, increasing the risk of harm to users. These powers will allow us to set up the new testing regime for vapes, nicotine products and tobacco products to ensure that they can be regularly tested to check that they are safe for consumers.

Speaker

Powers in the Bill will allow a fee to be charged for the ongoing and continuous testing of products. As with other measures, the exact details of those fees will be subject to future consultation. On clause 100, it might be worth reminding the Committee that the current rules on product safety all come from the Tobacco and Related Products Regulations 2016, which set out the current requirements for producers of nicotine vapes to establish and maintain a system about all the suspected adverse effects on human health from a product.

Speaker

The Government think we need the new product safety powers because vapes and nicotine products contain harmful ingredients, as we have already ascertained in the course of our deliberations. Especially if products are not delivered safely, as per our regulations, and if they pose a risk to users, producers must be able to take swift action by letting suppliers and retailers know when a product contains faulty or illicit elements. It is vital, then, that producers have processes in place to collect information on the effect of their product on human health, as well as a system to let producers and agencies know if a risk has been identified by them or by the enforcement agencies. This will positively impact enforcement, with a more robust system for monitoring and tracking non-compliant products.

Speaker

We have heard from the hon. Member for Farnham and Bordon about burdens on business. We are very attuned to those concerns, but we do believe that this is an appropriate balance, a necessary inclusion that bolsters safety regulations, and that much of it is already in place for nicotine vapes anyway. There will be an implementation period for businesses before any new regulations come into force, the length of which will be considered as part of the consultation process.

Speaker

On the point about international co-operation, because for some of these items it is a global marketplace and with online trading, we have to consider that some of these products may be coming from outside the United Kingdom, how will the UK work with international bodies? Products will be registered—as I have already said—in the UK, which will help to reduce illicit sales. We are already a committed member of the framework convention on tobacco control. United Kingdom enforcement authorities regularly speak to their international counterpart bodies and other states to deal with these challenges. Of course, His Majesty’s Revenue and Customs and Border Force already co-operate on illicit tobacco and vapes and a whole range of other things with our international partners anyway. The powers in the Bill will bolster that co-operation.

Speaker

Why have we chosen an overly regulatory approach? Why have we been so permissive in granting powers to the Secretary of State and Ministers in Scotland, Wales and Northern Ireland, rather than placing things on the face of the Bill? In part, the shadow Minister answered her own questions: it is partly to keep up with industry and to be one step ahead of any moves that may happen. However, the bit she omitted is that the Bill covers four nations—four jurisdictions—and if we were overly prescriptive in respect of the desires of England, it would not fit the purposes of Wales, Scotland and Northern Ireland. Working with the three devolved Administrations, the Government are content that, by granting Ministers powers to pursue consultations and regulations that appertain to the desires of those parts of the United Kingdom, we can get a better, stronger Bill.

Speaker

Question put and agreed to.

Speaker

Clause 99 accordingly ordered to stand part of the Bill.

Speaker

Clause 100 ordered to stand part of the Bill.

Speaker

Clause 101

Speaker

Matters dealt with by 2016 regulations

Speaker

Question proposed, That the clause stand part of the Bill.

Speaker

With this it will be convenient to discuss clause 102 stand part.

Clauses 101 and 102 deal with the treatment of, and matters dealt with by, the 2016 tobacco regulations. Again, they provide the Secretary of State with powers to make regulations. Whether or not that will be done well, we are not really sure at this stage. I understand the point the Minister made in response to the last debate, and it is of course true that regulations can be different in each part of the United Kingdom. In his discussions with Ministers in Wales, Scotland and Northern Ireland, they may have wished to proceed with regulations after the Bill, rather than to put them on the face of the Bill. However, that does not explain why the Minister has chosen to do the same, and I would be grateful if he could explain his choice to make regulations after the Bill, rather than to put them on the face of the Bill, with the power to modify. I ask particularly because we are now into, I think, the 12th consecutive clause that provides powers to regulate and that offers detail only on what any regulations might or might not say, rather than necessarily on what they will say. In that vein, clause 101 outlines provisions to allow the Secretary of State to make regulations similar to, or corresponding with, the Tobacco and Related Products Regulations 2016. That is to be done under a new regulatory framework, which would seem to be designed to cover gaps that may exist in the powers under those regulations. Subsection (1) says: “The Secretary of State may by regulations make provision…that is similar to or that corresponds to any provision of the Tobacco and Related Products Regulations 2016…other than Part 7 of those Regulations”. Part 7 of those regulations deals with electronic cigarette advertising. The Minister may feel that later parts of the Bill will deal adequately with this point, but I would be grateful if he could explain why that part has been taken out. That is not instinctive, because other aspects of those regulations could be too. What is the reason for excluding that part? Otherwise, I have no particular points to make about clauses 101 and 102.

Clause 101 allows the Secretary of State to make regulations similar to any provisions set out in the Tobacco and Related Products Regulations 2016 —the TRPR, which we discussed in our debate on the earlier clauses—thereby amending them if needed. In 2016, the TRPR implemented the 2014 EU tobacco products directive. The TRPR deals with the manufacture, presentation and sale of tobacco and related products, including herbal products for smoking, nicotine, vapes and refill containers, as well as smokeless and novel tobacco products. However, it does not regulate all products. As we know, new nicotine products such as nicotine pouches have emerged on the market—we discussed such things in our earlier deliberations—and we currently have no powers to change the regulations. We are also limited in what we can do within the existing powers—for example, on vape packaging. The Bill builds on the TRPR and allows us to go much further, with new powers on, for instance, packaging and flavour requirements, and new registration powers that could be extended to non-nicotine vapes, nicotine pouches, heated tobacco devices and cigarette papers. As we have ascertained, the tobacco and vaping industries are extremely innovative and have previously attempted to circumvent regulations and exploit loopholes. The clause helps to stop them doing that by allowing us to amend the TRPR if necessary. Clause 102 enables regulations to be made under powers in part 5 of the Bill to amend provisions in the Tobacco and Related Products Regulations that are within scope of those powers. This is a technical provision because, as I said in the previous debate, we have limited powers to amend the TRPR. For instance, if we introduce new vape packaging requirements using powers in the Bill, the clause will allow us to amend the TRPR if necessary, so that the new packaging requirements fit with those imposed under the TRPR. The shadow Minister raised issues relating to secondary legislation. The technical and detailed nature of many of the Bill’s requirements means that they are not suitable to be put on the face of the Bill. For example, we may need to amend those requirements in response to market changes. It is also necessary to include detail on the circumstances of when products must be recalled, which will change over time. There is a broader point here: with all the regulations that we propose to bring before Parliament, we want to get the measures right. We have a statutory duty in the Bill to consult before bringing in regulations, which is in part why we are making the measures in the way that we are. Part 7 of the TRPR is excluded because those things will now be in part 6 of the Bill. I commend the clauses to the Committee. Question put and agreed to. Clause 101 accordingly ordered to stand part of the Bill. Clauses 102 to 104 ordered to stand part of the Bill. Clause 105 Sub-delegation Question proposed, That the clause stand part of the Bill.

Speaker

With this it will be convenient to discuss clauses 106 to 111 stand part.

Speaker

00:00:00

Clause 105 states: “Regulations under this Part may confer discretions.” I confess that I do not understand what that means. I would be grateful for the Minister’s explanation. Clause 106 is about the power to make provision binding on the Crown, which we have discussed at some length. My only point is on subsection (4), which clarifies that public servants are still accountable under the regulations. Some may have concerns about the enforcement of regulations within Government bodies. Could the Minister say anything further on that? Clause 107 gives the Secretary of State power to make amendments to this legislation through regulations. It is quite a broad and flexible position: the Government can remove outdated laws that are inconsistent with new regulations established under the Bill and ensure that the regulatory framework can evolve. To some extent, that makes sense. Again, the Government seem to be keen to ensure that they can stay one step ahead of a very adaptable industry and try to protect the country from nicotine addiction. However, the clause is quite broad. I would be grateful if the Minister could further elaborate on his intent in it. Clause 108 provides for the consequential removal of section 94 of the Children and Families Act 2014 because it is no longer needed. Clause 109 is about enforcement. Clause 110 is about the consultation process. The requirement to consult before making regulations promotes transparency and accountability in the decision-making process and allows for adjustments and feedback from various groups, in the same way that line-by-line scrutiny of the Bill allows adjustment in line with discussion. It ensures that regulations are fair and based on a broad range of insights and evidence. However, I would be keen for the consultation not to be so long as to delay bringing in the regulations. As I have said before, much of the Bill hinges on the regulations the Government can provide. If the consultation processes are very long and drawn out, it could be a long time before any of these measures come into force to protect our children, in particular.

Sub-delegation allows functions to be carried out by someone who is not named in the primary legislation. We believe that that is vital for flexible implementation of Government policy and to keep the wheels of Government turning. Sub-delegation is a long-accepted part of the legislative process, and having the ability to allow technical experts to undertake technical tasks, or to set out very detailed technical criteria in guidance instead of using parliamentary resource, will allow us to get on with implementing the measures in part 5 of the Bill. The shadow Minister is right to be concerned about having safeguards to ensure that any sub-delegation of authority is not abused. Sub-delegation to persons must be set out in regulations. As I have previously said, there is also a statutory duty to consult on any regulations made under part 5. The regulations will be subject to the affirmative procedure, meaning that Parliament will have an opportunity to consider any sub-delegation before the regulations take legal effect. On the wider consultation the shadow Minister referred to, the Government chose to include consultation clauses because we want valuable input from different stakeholders on our proposals before they are introduced. As is conventional with such clauses in primary legislation, the clause does not prescribe the specific people the Secretary of State must consult. That is to ensure that the Government can consult appropriate stakeholders, and the list may evolve over time. UK-wide regulations made under part 5 might deal with devolved matters. The UK Government are therefore required to seek consent from the devolved Governments. My Department will continue to work closely with the devolved Governments on proposals for UK-wide regulation of products. I therefore commend the clauses to the Committee. Question put and agreed to. Clause 105 accordingly ordered to stand part of the Bill. Clauses 106 to 113 ordered to stand part of the Bill. Clause 114 Publishing advertisements

I beg to move amendment 87, in clause 114, page 63, line 16, after “product,” insert “except for the public health purpose of promoting vaping as a cessation tool for existing tobacco smokers,”. This amendment would allow vapes to be promoted as a quit-aid/public health measure.

Speaker

With this it will be convenient to discuss the following: Clause stand part. Amendment 88, in clause 115, page 64, line 3, after “product,” insert “except for the public health purpose of promoting vaping as a cessation tool for existing tobacco smokers,”. This amendment would allow vapes to be promoted as a quit-aid/public health measure. Clause 115 stand part. Amendment 89, in clause 116, page 64, line 30, after “product,” insert “except for the public health purpose of promoting vaping as a cessation tool for existing tobacco smokers,”. This amendment would allow vapes to be promoted as a quit-aid/public health measure. Clause 116 stand part. Amendment 90, in clause 117, page 65, line 18, after “product,” insert “except for the public health purpose of promoting vaping as a cessation tool for existing tobacco smokers,”. This amendment would allow vapes to be promoted as a quit-aid/public health measure. Clause 117 stand part. Amendment 91, in clause 118, page 66, line 3, after “product,” insert “except for the public health purpose of promoting vaping as a cessation tool for existing tobacco smokers,”. This amendment would allow vapes to be promoted as a quit-aid/public health measure. Clause 118 stand part. Amendment 92, in clause 119, page 67, line 8, after “product,” insert “except for the public health purpose of promoting vaping as a cessation tool for existing tobacco smokers,”. This amendment would allow vapes to be promoted as a quit-aid/public health measure. Amendment 93, in clause 119, page 67, line 24, after “product,” insert “except for the public health purpose of promoting vaping as a cessation tool for existing tobacco smokers,”. This amendment would allow vapes to be promoted as a quit-aid/public health measure. Clause 119 stand part. Before I call the shadow Minister to speak to amendment 87, I should indicate to her that, since the clauses each have amendments proposed to them, it would be helpful to know as we work through the debate whether she wishes to press them to a vote.

Amendment 87 is to clause 114. This group of clauses represents a substantial part of the Bill, as it applies to advertising and sponsorship. Those became an issue as part of the Health and Social Care Committee review of vapes back in the last Parliament. They were also discussed during debate on the last iteration of the Bill last Easter. In fact, I tabled a fair number of amendments on the subject in the last Parliament. Clause 114 creates an offence where a person, acting in the course of business, publishes an advertisement in the UK promoting certain regulated products such as tobacco, herbal smoking products, cigarette papers, vaping products and nicotine products. To commit the offence, the person must know, or have reason to suspect, that they are publishing advertisements for such products and that the advertisement will promote those items. Subsection (2) outlines the penalty for this offence, which is up to two years in prison, a fine or both. For summary conviction, the penalties vary by jurisdiction, with different maximum prison terms in England and Wales, Scotland and Northern Ireland, but a fine may be imposed in all cases. The clause aims to regulate the advertising of tobacco and nicotine products by placing responsibility on businesses and individuals publishing such advertisements, to ensure they comply with the law. I return to the question asked by my hon. Friend the Member for South Northamptonshire regarding use of the word “publish”, and I have in mind particularly the online environment. Could the Minister confirm who is the publisher of, for example, a TikTok video? Is it the individual who uploaded it, or is it TikTok itself? I also have a question about the words “purpose” and “effect”. Are they too vague? Could they lead to overreach and confusion about what constitutes promotion? It is unclear whether an advertisement needs to explicitly promote a product or whether a more subtle influence will be sufficient. How broad does the Minister intend the interpretation of “purpose” and “effect” to be? Can an advertisement for a lifestyle product that features someone smoking or vaping in the imagery be considered as promoting a tobacco product, even if it is not the main focus? Another issue arises from the clause’s reliance on subjective knowledge or suspicion. The clause states that a person commits an offence if they know or have reason to suspect that the advertisement has the purpose or effect or promoting the product. In cases where the individual involved in the publication of an advertisement did not have direct knowledge of, or did not suspect, the advertisement’s purpose, what level of proof is required to say that they “know” or “have reason to suspect”? For example, if an advertisement is published by the third-party platform or agency, perhaps online, can a person who did not directly control the advertisement’s creation still be held liable? This is really important when it comes to the online world, where the sheer volume of hosts may make it incredibly challenging for an online provider to look at every single post that is put up. On advertising, the impact assessment provided by the Government says on page 101: “Despite advertising restrictions existing for nicotine vapes in some settings including television, radio and through information society services, such as internet advertising or commercial email, evidence shows advertising is noticed more by young people, and this has increased in some settings in recent years. Additionally, despite being prohibited under TRPR, the ASA report social media is increasingly being used to advertise vapes to children.” I note the differences between the devolved nations. Under the Health (Tobacco, Nicotine etc. and Care) (Scotland) Act 2016, Scotland has powers to go further on advertising and sponsorship—for example, powers to ban nicotine vape advertising in more settings than those in TRPR, to ban sponsorship agreements involving nicotine vapes, and to introduce regulations on brand sharing. Paragraph 655 of the impact assessment says: “CRUK estimate the annual cost of advertising for the sector in 2019 was £32m. Under this policy proposal, no advertising would be permitted so this previous cost would be saved by businesses, and partially offsetting their lost profits from reduced vape sales outlined in the monetised costs section.” Paragraph 666 states: “Similar to the monetised benefits above for vapes, businesses who currently fund advertising of nicotine products, herbal smoking products, and/or cigarette papers will save this money”. Of course, advertising companies will need to find their revenue somewhere else. To me, it seems sensible to restrict the advertisement of these products, as I said before. We must remember that young people are at the heart of this Bill, and the impact assessment also notes how susceptible young people are to advertising and why this clause is of particular relevance. Paragraph 499 highlights a survey conducted by Cancer Research showing that advertising is more noticed by young people. The survey results reveal that “for all types of media analysed, apart from ‘email/SMS’, youth (16 to 19 years) noticed advertisements more than adults (18 years and older) in 2018 in England. The locations and media channels surveyed included: inside shops selling cigarettes; kiosks; web/social media; billboards/posters; newspapers/magazines; events/festivals; bars/pubs; and email/SMS. The largest difference in the two age groups was seen for 'billboards and posters’ with 31.4% of youth noticing marketing compared to 5.9% of adults.” It also notes that “youth (16 to 19 year olds) never users (who have never smoked or vaped) report higher noticing of vape advertising across all media types, apart from email/SMS compared to adult exclusive smokers”. Action on Smoking and Health did a survey which found that “more than half (55%) of 11 to 17-year-olds are aware of vape promotion in shops compared to 37% two years ago, while 15% see adverts on billboards, up from 12% two years ago.” It is clear that advertising needs to be restricted. Amendments 87 to 92 ask the Minister to consider how to ensure that people who are smokers understand the information that is available to help them quit. At the moment, a smoker might go into a doctor’s surgery or an antenatal clinic and see information on smoking being bad for them, which is appropriate. They may also see information on opportunities for nicotine replacement therapies, or even on vaping as an alternative. If the Minister is keen to ensure that people who are smokers can use vapes as an alternative, which is believed to potentially be better for them than continuing to smoke, how will they be given that information if the products cannot be advertised or promoted?

Tristan Osborne

The hon. Lady is eloquently articulating the necessity of controls around advertising. Does she share my concern about the risk of creating a loophole, whereby advertising could still happen if there were warning notes on adverts? The Bill seeks to reduce any type of loophole through which an advertiser might promote vaping—with words underneath that this is a smoking cessation device—in all settings. Does she also agree that the NHS is already able to articulate smoking cessation methods to patients, without the need for brand advertising?

Speaker

12:15:00

The hon. Gentleman and I agree that we need to restrict the advertising of these products, because we do not want people, particularly young people and children, to start becoming addicted to nicotine. We agree on that. However, the Bill does not say an advert needs to promote a brand of nicotine product to be considered promotion or illegal under the Bill. It simply says “a nicotine product” or “a tobacco product”. I am keen to ensure the Minister clarifies that a doctor—I declare an interest as a doctor—or other health professional such as a pharmacist, like the hon. Member for North Somerset, will not find him or herself on the wrong side of the law for promoting vaping to individuals who smoke.

Sadik Al-Hassan

It is a pleasure to serve under your chairmanship, Sir Roger. Current medicine regulations do not allow products to be advertised, but do not get in the way of smoking cessation clinics that currently take place at GP surgeries or pharmacies. The amendments the hon. Lady is proposing are, therefore, not needed. In fact, as my hon. Friend the Member for Chatham and Aylesford suggests, they could be used as a loophole for advertising by an industry that has been shown to be very successful at finding ways around legislation to increase market share and the numbers of smokers and vapers.

I thank the hon. Gentleman for his intervention. He comes to this debate with significant experience as a pharmacist himself. In bringing forward this amendment, it is not our intention to create a loophole. None of us wants to see children vaping or using nicotine products and developing an addiction they struggle to quit for the rest of their lives, with the associated costs to their health and their purses. However, I want the Minister to assure the Committee that he has considered the position of pharmacists and people who will legally be selling these products as a stop smoking device, perhaps in a hospital clinic or as a health professional, and made sure they will not be criminalised. If we are to follow the chief medical officer’s advice—that vaping is not suitable for children but is suitable for adults who smoke as a harm reduction measure—and are to have that harm reduction process in place, which I believe is the Minister’s intention, it is important to consider how it will continue under these regulations. It is important to consider how pharmacists and other health professionals will be able to have discussions with their patients or clients in which they may wish to say, “Vaping is better for you,” and in so doing effectively promote the process—not a specific product, but the genre of products.

Mr Alex Barros-Curtis

I thank the hon. Lady for giving way. I share the concerns expressed by the shadow Minister and by my hon. Friends about inadvertently creating a loophole, which we know the tobacco industry and others will drive a coach and horses through. I understand that part of the purpose of tabling the amendments is to get reassurance and clarity on certain aspects of the Bill, but on the point she was just making, is not the relevant provision subsection (1)(a), which refers to the person “acting in the course of business”? I am sure the Minister will clarify later, but perhaps the clause deals not with medical practitioners, pharmacists or doctors, but with media agencies or companies whose reason to exist is as a business for selling media, for publishing, for design. They do not operate cessation services and are not medical professionals or pharmacists themselves. In the realm of instructions to a service industry, whether it be a publisher or a business that designs advertisements, does this provision not simply make it crystal clear that, no caveats, they cannot do anything that is listed in the clause, because to do so will be an offence?

I thank the hon. Gentleman for his intervention, but while pharmacists are highly trained clinicians with the capacity to prescribe a number of products in specific cases, they are also businesses. One’s local pharmacy is a business. Pharmacists sell products; they take money and make variable amounts of profit. A GP is a private entity, as the Minister will have learned during the national insurance contributions debate. Some GP practices are dispensing practices—the GP prescribes a product, which is dispensed from that practice. There are also private clinicians who provide GP surgery or stop smoking services at a price. I do not think that “in the course of business” necessarily provides the distinction that the hon. Member for Cardiff West hopes it does, but perhaps the Minister will provide further clarity. It might be possible for the Minister to include an extremely narrowly drafted exemption for medical professionals providing advice in relation to stop smoking services and antenatal clinics giving advice to a current smoker, but perhaps he feels that those clinicians are covered already. One of the reasons for tabling the amendments is to have this debate and ensure that the clauses are carefully considered. All of us, on both sides of the Committee and the House, want to improve the health of the nation; we all want the Bill to improve the health of the nation. If the chief medical officer’s advice is that for adult smokers, vaping is better, those products need to be available to adult smokers. I will move on to clause 115, which extends the offence in clause 114 of publishing advertisements to those who design the advertisements for regulated products, such as tobacco products, herbal smoking products, cigarette papers, vaping products and nicotine products. As in clause 114, to commit the offence the person must know that the advert has the purpose of promoting one of the regulated products and that it will be published in the UK. The latter part is important. Again, I would like the Minister to ensure that there is no loophole for people to design things and say they are expecting them to be promoted abroad, and then they are promoted in the UK. That could be quite a significant loophole. Businesses could get around that with contract clauses, I suspect. Subsection (2) establishes the penalties for the offence, which are a conviction on indictment of two years, a fine or both. Summary convictions carry varying penalties based on the jurisdiction in which the offence was committed. That does leave the situation where somebody who has committed the same offence in England, Scotland and Wales by publishing it across those jurisdictions could face several different fines in different jurisdictions for exactly the same advert. Another question is about the designers. Individuals may be involved in the design of advertisements, but not have full control over the final content or how the advertisement will be published. Should liability be extended to individuals working on the design, or should it lie more squarely with the business or entity that ultimately publishes it? Is it fair to hold designers accountable for advertisements over which they have limited control? If they have only designed part of the advertisement, and it is not the bit in which the product is promoted, will they still be liable for the whole advertisement? Clause 116 introduces another offence, this time for businesses that print advertisements that promote tobacco products, herbal smoking products, cigarette papers, vaping products and nicotine products. They must know or have reason to suspect that they are printing an advertisement for those products—if they are printing it, they should know what they are printing—and that the advertisement will be published in the UK. Again, that will presumably have to be dealt with by contract law and involve some quite significant fines. Clause 117 makes it an offence for persons acting in the course of business to distribute the advertisement. The question here is about physical and digital adverts. If a person is distributing the adverts on a sheet of paper, putting billboards on the wall or driving around a truck with a billboard on the back, it is clear that they know what they are doing and it is clear who is doing it. If adverts are appearing online or being distributed online, can the Minister specify who will be held responsible? Could somebody sharing an image that was produced by somebody else be a loophole? Clause 118 expands the scope of responsibility to those who cause advertisements to be published and distributed within the UK. That seems sensible. Clause 119 is the Government’s attempt to focus on the businesses that provide internet services. The provision is quite broad. Not all providers are UK-based, though. If they are not, how can they be held accountable? The provision could be seen to apply to various types of online platform, including social media search engines and website hosts. The key issue is whether a business that merely provides a platform or service for the publishing and distribution of advertisements can be held liable for content that is uploaded or shared by third parties, particularly where there is a huge volume. The clause places responsibility on service providers that know or have reason to suspect that advertisements promoting tobacco or vaping products will be distributed through its services. That could apply to a wide range of internet service providers, from major global tech companies that are household names to the smaller, niche providers that operate in the UK market. I understand why that is important, but will the Minister say more about the person who is paying for the advertisement? The Bill covers publishing, designing and distributing an advert and providing it on the internet, but what about the individual paying for it? Ultimately, an advertisement rarely comes for free. How is that to be regarded? The measures to reduce advertising for vapes and smoking products are sensible public health measures to reduce uptake. As we discussed in the debate on diet and obesity earlier this week, advertising clearly works. I recalled in that debate some of the adverts I remember from my childhood, such as “The red car and the blue car had a race” for Milky Way—I was pleased that the blue car won in that case, Sir Roger—and “A finger of fudge is just enough to give your kids a treat”. Those memories stick in the mind for many years. Advertising is effective and induces children to try products, so banning advertising for vaping and smoking products should be very beneficial, but I urge the Minister to consider whether he has covered the full scope of those who are responsible for adverts and at the same time excluded those who may play only a very small part in the advert and not realise that it will later become an advert for a smoking or vaping product. Has he considered carefully how a medical professional, clinician, pharmacist or similar person can still provide and openly discuss vaping products with their patients and clients, so that they can use them as a quit aid?

Sarah Bool

It is a pleasure to serve under your chairmanship, Sir Roger. I just want to go through something again. Obviously, the purpose of part 6 of the Bill is to establish the rules about advertising, which I completely understand. It sets out that it is an offence for a person in the course of business to publish an advertisement, to promote products, to design advertisements, to print an advertisement, to distribute an advertisement, to cause publication, design, printing or distribution in the UK, or to provide an internet service by means of which an advertisement is published or distributed.

Speaker

12:30:00

Speaker

What I am really trying to understand, particularly when we are talking about the “person” who commits the offence, is whether there will be further regulations, which perhaps the Minister can confirm, about who that is. This provision is really designed for companies: we want to ensure that the companies are not breaching these rules about advertisements. When the Bill talks about a person, my concern is about who within the company is actually the relevant person. Is it one of the senior directors? Is it the person who was responsible for publishing the social media post? I just want to get a bit of clarity, because the punishments that come as a result, imprisonment or a fine, are obviously aimed at an individual. I do not know whether there has been further thought about how we can ensure that the companies themselves are responsible.

Speaker

It is interesting to consider how this will ultimately play out in relation to the online world, because there are punishments and restrictions on those who provide the internet service. Obviously, that is aimed at the Instagrams, Facebooks and other corporations but, again, the offences are aimed at an individual. When it comes to a corporation as big as those, I am intrigued to see not only exactly who we think will be captured by the offence, but how that will work in relation to social media influencers, which I talked a lot about last week— I seem to be totally obsessed with Instagram. Perhaps I spend too much time on it. In relation to the offence of distributing an advert, all influencers obviously have to declare as part of their post, “This is an #ad,” to ensure that everyone knows that they are promoting a product, so it will be very clear if they are committing a breach, but if a fellow influencer shares a post from someone else—perhaps an influencer from outside the UK again—how do we ensure that they are caught? This is a niche point and a technicality, but I always look to a lawyer’s brain to see how they will find little flaws in the provision, and anything further that the Minister can say in that regard would be much appreciated.

I do not intend to opine for very long on these clauses, because they have been covered amply by my hon. Friends. I caveat everything I am about to say with an absolute commitment: I continue to believe that this is the right Bill, that the clauses that we are discussing are the right clauses, that we should be trying to stop people smoking tobacco products and that people under 18 should not have any access to vapes. However, I have mentioned on a number of occasions that vapes could be and are used as a smoking cessation tool. This is why I perhaps go further in my desire than the shadow Minister does in relation to the amendments that she has put forward. I do not know whether she will press them, but I do ask the Minister to think about the issue of smoking cessation. The shadow Minister talks about how someone who is promoting smoking cessation might fall foul of these rules as they are written—the Minister shakes his head, and I am sure that he will be able to give us reasons for that in a minute. I would go one step further. For example, we allow the promotion and advertisement of gums and nicotine patches, because they are classed as a medical product, being effective smoking cessation tools. Of course we do not want anybody who does not smoke, either an adult or a child, to be chewing nicotine gum or wearing nicotine patches—to be frank, I am not clear whether there is any evidence that they do, but I suspect they are not seen as, to use the word I think the Minister used last week, “sexy”. I do not think anyone thinks that chewing gum is particularly sexy, and certainly a patch on the arm is not sexy, so I accept that those are not in the same bracket as a vape with colourful packaging and so on. However, gums and nicotine patches are monitored by the MHRA. I know that the Minister has indicated that a new home is being sought for vapes, but as it stands in the law, they would be monitored by the MHRA. If we are going to say that they are in a similar vein to a patch or a gum in terms of smoking cessation, it is possible that we might want to be able to promote and publicise them, maybe through something in a doctor’s surgery or in a maternity ward, as my hon. Friend the shadow Minister said, that says, “Don’t smoke. Instead, use a vape, a patch or a gum.” If that advert in a doctor’s surgery said “gum” or “patch”, there would be no problem, but if it said “vape”, my understanding is that it would fall foul of these clauses. As my hon. Friend said, they may not want to fall foul of the law, but we might want to be able to advertise vapes as a smoking cessation tool in that very limited circumstance and in an appropriate place—that is, in a pharmacy or a doctor’s surgery.

Dr Beccy Cooper

I want to add something to what the hon. Gentleman is saying, which is interesting and relevant, about smoking cessation services and how they currently work. I have run and managed smoking cessation services. As it stands, when a smoking cessation adviser is talking to a person who wants to stop smoking, they discuss nicotine patches, gum and whatever other options may be available. They do not promote vapes or actively say that they are an option. The reason for that is the public health evidence. In public health, we apply the precautionary principle, by and large, where we think that there may well be harms ensuing from using a particular product, but the evidence is not yet sufficient. The hon. Gentleman is absolutely right that, in the case of smoking, using vapes is much more preferable for a person’s health, but in terms of smoking cessation, as clinicians and advisers, we need to be careful in how we apply clinical norms, and that is relevant here.

The hon. Lady makes an interesting point. I will not labour my point any further, because I think I have made it; I am sure that the Minister can respond to it when we get there. The only other thing I will mention is the online advertisements mentioned in a number of the clauses. Is the intention to do with the website displaying the advert, the person who has put forward the advert or the intermediary companies? Online, a lot of adverts are now tailored via cookies. When the Minister goes on to a website, the adverts that he sees are tailored to the things that he has been looking at. I could go on to exactly the same website at exactly the same time and receive a different set of advertisements based on my internet viewing preferences—[Laughter.] I do not know why my hon. Friend the Member for Windsor is laughing. I get a lot of weird stuff, mostly for hoof trimming videos—I am not sure what I typed in to get those. Maybe it is my rural seat. I do not know. My point is that those advertisements are totally unconnected to the website that I am looking at, which essentially has no control over what adverts are being displayed, as far as I understand it. Because the internet is so complicated, what thoughts does the Minister have about the fact that essentially, the internet provider and the website may not have any knowledge of what adverts are being put on?

Dr Danny Chambers

As part of the solution, legislation must already be in place, because human and veterinary prescription-only drugs are not allowed to be advertised to the public, but they can be advertised to medical professionals. There must be legislation that prevents rogue companies from advertising in the UK products that they are not allowed to advertise to the general public, and I imagine that it should be incorporated into the Bill to address the problem that the hon. Gentleman talks about.

Forgive me; I am not sure I fully understand the hon. Member’s point in relation to what I was just saying, but that is probably because I have not explained myself well enough, not because he has misunderstood it. I entirely agree that the advertising of tobacco and vape products should be banned, and I agree with the sentiment and the outline in the law. All I am saying is that when the Minister or the relevant authority seeks to prosecute somebody for this offence, there may be occasions, given the complexity of the internet these days, when people may not know that their website is hosting said adverts. I do not want to labour that point again, but I am sure the Minister can respond.

Members will be glad to know that I have curtailed my remarks, because the Conservative Benches almost seem to be in agreement, which will delight the Whip. However, I do have concerns about part 6 and some questions on a couple of specific points, and I would appreciate it if the Minister considered them. One of my concerns is the potential weakness of the public consultation aspect. It is my understanding that other parts of this Bill—particularly flavours and packaging restrictions—will be consulted on before secondary legislation is introduced, but that that is not necessarily the case for this part. This part should be subject to that same level of public scrutiny. It seems to me that experts, consumers, retailers and even legitimate parts of the vaping industry should have the opportunity to have their views heard on these clauses before the Government move forward with the legislation. The first of the overriding concerns that have been articulated is that the Government should not accidentally make it harder for adult smokers to switch to vapes and other safer nicotine products. The Government’s own risk assessment mentions that as a risk, so I would welcome the Minister’s comments on that. Secondly, we have to be a little bit careful about imposing burdensome restrictions on compliant small businesses, particularly convenience stores. It is my understanding that, for some convenience stores, up to a quarter of their sales come from tobacco and vapes. On the top lines on part 6, it seems to me that the advertising and promotion of vapes and other nicotine products, including nicotine patches, could very well be an effective means of reaching adult smokers and helping them to switch. What assessment has the Minister made regarding the effect on switching rates that this advertising ban may have? ASH reported that half of smokers incorrectly believed that vaping was more harmful than, or equally harmful to, smoking, and that trend is one that has increased. Is the Minister not concerned that, by banning the advertisement of these products, the Government could be at risk of inadvertently exacerbating that problem and undermining its own public health messaging that “Nicotine vaping is substantially less harmful than smoking”? To my mind, if we are to continue to encourage smokers to switch, it is crucial that they are aware of the relative risks of vapes and nicotine patches compared with cigarettes. I know that the Minister has made the point that no level of use is safe, but we are talking about the relative risks here. To my mind, there should be provision in this legislation to allow for the promotion of information on the relative harms of vapes and nicotine patches compared with cigarettes. I think that is part of the nub of what my hon. Friend the shadow Minister is getting at.

My hon. Friend is making some good points about the importance of ensuring that people can access nicotine replacement therapy in its various forms if they wish to stop smoking, because that will be healthier for them. I understand what the hon. Member for Winchester has said about prescription-only medicines, and that it is illegal to advertise prescription-only medicines to the public, but not all nicotine replacement therapies are prescription-only medicines, so those can be advertised to the public at the moment.

I thank my hon. Friend for her comment. I was struck in the written evidence—we have been overwhelmed with written submissions; I am not sure whether we were expected to read them all—by a comment by a Professor Peter Hajek when he was speaking to the Health and Social Care Select Committee. He said: “In Tokyo there were huge, big posters showing the risk of smoking and, at one tenth of it, in a histogram, was the risk of IQOS”— I would translate “IQOS” as heated tobacco. He then said: “Within about five years—it has never happened before and is a fantastic achievement for public health without any involvement of Government—sales of cigarettes in Japan dropped by 50%.” As I understand it from his description of that histogram, it was an advert by a private heated tobacco company, showing the relative sizes of the risks of cigarettes and of heated tobacco. That is something that this advertisement ban might prohibit, but that might help the Government in their aims to move to a smoke-free generation.

Speaker

12:45:00

I am afraid I might need to break the happy agreement on the Conservative side. While I understand my hon. Friend’s laudable aim of encouraging those who smoke to use a less harmful product, which is a good thing, the clear evidence we have seen is that tobacco, in all its forms, is essentially harmful. Moving people from smoking tobacco in cigarettes to using heated tobacco may or may not reduce the harm, but it would still be significantly harmful. It would be better if an individual saw their pharmacist or clinician to get proper nicotine therapy, which is designated by the MHRA as a properly medically regulated product, rather than moving on to a different commercial product that is still harmful for them.

My hon. Friend makes her point well, and she is right that there is a slight disagreement between us. The Government should be wary—

rose—

I am going to make some progress. Even judging by the Government’s own standards, we should be treating vaped tobacco and heated tobacco very differently from cigarettes. We should be a little careful about the unintended consequences of this measure, and I hope the Minister can say how he might consult other bodies to look at those unintended consequences. I have a small concern with the internet services measure in clause 119. Again, it seems that the Government’s aims in this legislation is to prevent targeted communication on vapes and nicotine products to adult smokers, such as via emails or digital channels, which can reach them directly. I understand the point about not wanting to aim such communication at children, but targeted communication, such as using people’s internet search history, could be an effective means of encouraging smokers to quit. I mentioned a few weeks ago the work that NHS Essex is doing with a vaping company, targeted at adult smokers. I do not think the Government, in achieving their aims of a smoke-free generation, should be too prescriptive on this.

I am grateful to hon. Members for our discussion on amendment 87 and subsequent clauses. These amendments intend to make an exemption under the advertisement ban to allow vaping products to be promoted by businesses as a smoking cessation tool for existing tobacco smokers. I am sympathetic to the shadow Minister’s intention behind the amendment to ensure that smokers are encouraged to use vapes as a quit aid. That is why the Bill as drafted will continue to support the promotion of vaping as a quit aid for smokers through the appropriate channels. By “appropriate channels”, I say to the hon. Lady that we mean public health authorities.

I want to clarify one small point, if I have not made myself completely clear. On a personal level, I do not particularly want people to be persuaded to go from smoking to vaping, because I think it is an alternative addiction that they will get stuck on. I would much prefer them to be directed towards other forms of nicotine replacement therapy, which will be effective and more short lived. However, given that the current medical advice is that vaping is better, I think it is important that it is available.

I get that the shadow Minister is dancing on a pinhead, but she has brought to the Committee a set of amendments for which that would be the purpose. If they are pushed to a vote, I am sure we will have the bewilderment of the shadow Minister yet again abstaining on measures that the shadow Minister has brought before the Committee. We believe it is for public health authorities to promote vaping as a quit aid for current smokers. For example, local stop smoking services will continue to be able to promote vapes to smokers as a less harmful alternative following the passage of the Bill. We strongly believe that any promotion of vaping as a way to quit smoking is best led and delivered by the appropriate authorities, such as local stop smoking services, public health professionals and the national health service. The clauses in part 6 of the Bill, taken in totality, will form a complete ban on advertising and sponsorship for tobacco products, herbal smoking products, cigarette papers, vaping products and nicotine products, bringing them all in line with tobacco. It is unacceptable that children are exposed to vape adverts on the sides of buses and in shop windows when they make their way to school. Clauses 114 to 117 make it an offence for anyone “acting in the course of business” to publish, design, print or distribute an advertisement “whose purpose or effect is to promote” a relevant product within the Bill. Upon conviction, anyone who has committed an offence under part 6 will be liable to a fine, imprisonment or both. These clauses are an essential part of the overall suite of restrictions that will ban advertising of relevant products within the UK. Taken together they will ensure that even if someone has not designed or published an advert, it will still be an offence to print or distribute that advert. This is key to stopping their eventual distribution. I hope that answers the questions about whether there is a loophole allowing adverts produced for international markets to be distributed in the United Kingdom. The distribution of those adverts will be an offence. Clause 118 makes it an offence to cause the offences I have just set out. It would be an offence if a person “knows or has reason to suspect” that they are causing these things, whereas if someone unknowingly delivered a package containing leaflets, they would not be guilty of the offence. Without this clause, it would be possible to instruct others to publish, design, print or distribute adverts without committing an offence. Clearly, we need to ensure that it is also an offence to cause these things to happen. Lastly, clause 119 makes it an offence to provide an internet service in the course of a business by means of which an advert for a relevant product is published or distributed. This would mean that an organisation that provides a service to a person—for example, Sky or TalkTalk—would commit an offence if they provided a service that enabled the online advertisements to happen and if they permitted that space to be used to promote relevant products. That could include becoming aware that the service is hosting a vape advert and subsequently failing to take that advert down. This is particularly important, as young people, and some not-so-young—we now know that, if we have a hoof that needs trimming, the hon. Member for Farnham and Bordon is our man, although I am not sure whether he provides the service or just passes the request on—

Things haven’t got that bad yet.

Clause 119 is important, as children spend a lot of time online and therefore are more exposed to a variety of internet services. It is unacceptable that a child using the internet to study might be exposed to a variety of vape adverts. We need to take action to stop these products being deliberately advertised to children, to protect future generations from becoming hooked on nicotine. The shadow Minister’s amendments would in theory allow any shops or businesses to advertise vaping products to existing tobacco smokers. It would be incredibly difficult to target the advertisement of vaping products to current smokers alone, without the risk of children and non-smokers seeing the promotional material. That would not only make enforcement complicated, but make the messaging about the ban inconsistent. Research on tobacco advertising bans has shown that comprehensive bans were significantly more effective than partial restrictions in reducing smoking rates. Hon. Members has posed a number of questions, which I will address. What constitutes an advert and how will the decisions be made? The Advertising Standards Authority is the regulator, and it will take a proportionate approach. All adverts are captured. Decisions on whether something is an advert will be made on a case-by-case basis, and it is for the ASA to decide. If the purpose or effect of something is to promote a product, it will most likely be captured. I say to the hon. Member for Windsor, “Worry not”: the ASA knows how the internet works, because it is dealing with it daily, and as we speak. How does liability work? The offence will be charged on a case-by-case basis. In most cases, we expect that this will involve a company. The ASA is experienced in making decisions on tobacco restrictions at the moment, and the provision merely extends the powers and responsibilities that it is already undertaking with regard to a variety of other products. On social media influencers, it depends on how the ASA approaches the matter; if it decides that something is constituted as an advert, action can be taken. Nobody is above the law of the United Kingdom. The hon. Member for Windsor asked why we are making changes to the law without consulting. To be clear, tobacco adverts are already banned under the Tobacco Advertising and Promotion Act 2002, and the provisions in part 6 of the Bill will simply maintain the existing ban on tobacco advertisements. We were elected with a mandate to carry out our manifesto commitments, one of which was to stop the advertising of vapes to children. We already know that the measures to restrict vape advertising are strongly supported: 74% of adults in Great Britain support banning the advertising and promotion of e-cigarettes at point of sale, at the till, in stores and as people enter shops, and only 6% are opposed. Does aligning vapes with tobacco in this area contribute to misconceptions that vapes are just as harmful as tobacco? Although the approach towards vapes and towards tobacco will align in this area, our future regulations on other vape measures will be carefully considered so that there is a clear difference between these products. Given that vapes are less harmful than tobacco, we do not intend to treat them in exactly the same way as tobacco. To be clear, there is no more dangerous product that is legally sold in our shops than tobacco—a product that kills two thirds of its users—but we do not want to inadvertently addict a new generation to nicotine. That is the reason for the advertising measures. Will the ban on the advertising of heated tobacco products increase the demand for traditional cigarettes? The Department’s opinion is that heated tobacco products are covered under the 2002 Act, which prohibits the advertisement and sponsorship of tobacco products. The new definition just ensures clarity on the scope of the legislation, as well as future-proofing policy. This is not a new ban; we believe that the existing tobacco advertising ban appertains to heated tobacco products in any case. We very much want people to give up all forms of tobacco. That is why this Government have invested a further £70 million for smoking cessation services in the new financial year, and why I maintain that, although we are saying to tobacco companies, “This is as good as it gets,” we will move heaven and earth to shrink their customer base even further with appropriate smoking cessation. With that, I ask the shadow Minister to withdraw her amendment, and commend the clauses to the Committee.